Elevance Health stock pre-market at EUR 360.45: minus 0.18 percent
Published on 10/08/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elevance Health stock was EUR 360.45 pre-market at Lang & Schwarz at 8:10 a.m. CEST on October 8, 2026. The price was down 0.18 percent versus the prior close of EUR 361.10 on October 7, 2026. The quoted change was minus EUR 0.65.
Pre-market trading
Lang & Schwarz showed a bid of EUR 357.80 and an ask of EUR 363.10. The pre-market indication reflects trading in euros for investors in Germany before the Xetra session begins. The price and percentage change use the Lang & Schwarz reference close for the previous trading day. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.
Scheduled third-quarter results
On October 5, 2026, Elevance Health announced that it would release its third-quarter 2026 financial results on October 21, 2026, at 6:00 a.m. EDT. Management had scheduled a conference call to review the results and outlook at 8:30 a.m. EDT that day. The company said the webcast would be available through its investor-relations website. The announcement was issued in a company press release.
